1843 Capital

1843 is a women-led venture fund investing in the $30 trillion Age Tech and Longevity Revolution. We invest in technology companies that impact the health, independence and security of the aging populations. Our first fund has Net IRR of 26% (35% gross) and 54.7% for our AgeTech investments. 93% of our founders are diverse and our 3 female partners and one associate bring a combination of investing and operating experience to our investment process. We are one of the earliest to focus on the AgeTech space and have a deep network to generate deal flow.